Form 8-K - Current report:
SEC Accession No. 0000885590-22-000058
Filing Date
2022-11-03
Accepted
2022-11-03 07:13:27
Documents
14
Period of Report
2022-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhc-20221103.htm   iXBRL 8-K 39134
2 EX-99.1 ex991-q3x2022.htm EX-99.1 702849
6 BHC LOGO image2.jpg GRAPHIC 7860
  Complete submission text file 0000885590-22-000058.txt   940660

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20221103.xsd EX-101.SCH 1920
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20221103_lab.xml EX-101.LAB 25096
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20221103_pre.xml EX-101.PRE 13047
8 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20221103_htm.xml XML 11484
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 221356190
SIC: 2834 Pharmaceutical Preparations